Skip to main content
HR 478 116th Congress House Health Administrative law and regulatory procedures Canada Department of Health and Human Services Drug safety, medical device, and laboratory regulation Government information and archives Prescription drugs Trade restrictions

Safe and Affordable Drugs from Canada Act of 2019

Introduced: January 10, 2019 Introduced by: Pingree, Chellie Democratic · Maine See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 25, 2019
Referred to the Subcommittee on Health.
Jan 10, 2019
Referred to the House Committee on Energy and Commerce.
Jan 10, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Safe and Affordable Drugs from Canada Act of 2019

This bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy if the drug

  • is dispensed by a pharmacist licensed in Canada;
  • is purchased for personal use in quantities not greater than a 90-day supply;
  • is filled using a valid prescription issued by a physician licensed to practice in the United States; and
  • has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved by the FDA.

Under the bill, certain drugs may not be imported, including controlled substances and biological products.

The bill establishes a certification process for approving Canadian pharmacies. The FDA must publish a list of approved Canadian pharmacies.

What's happening now January 25, 2019

Referred to the Subcommittee on Health.

 Related & companion bills 2
  • S 3384 Related bill Lowering Prescription Drug Prices for America’s Seniors and Families Act of 2020
  • S 61 Identical bill Safe and Affordable Drugs from Canada Act of 2019
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 12
All 12 Democratic 9 Republican 2
R
Tiffany, Thomas P.
Wisconsin · Aug 11, 2020
 R
Joyce, David P.
Ohio · Oct 23, 2019
 D
Slotkin, Elissa
Michigan · Oct 17, 2019
 D
Khanna, Ro
California · May 10, 2019
 D
Craig, Angie
Minnesota · Mar 26, 2019
 D
Welch, Peter
Vermont · Feb 13, 2019
 D
Case, Ed
Hawaii · Jan 30, 2019
 D
Cohen, Steve
Tennessee · Jan 30, 2019
 D
Doggett, Lloyd
Texas · Jan 30, 2019
 D
Garamendi, John
California · Jan 30, 2019
 D
Golden, Jared F.
Maine · Jan 16, 2019
Herrera Beutler, Jaime
· Jan 10, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 478: Safe and Affordable Drugs from Canada Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-478/
MLA
"H.R. 478: Safe and Affordable Drugs from Canada Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-478/.
Bluebook (legal)
H.R. 478, 116th Cong. (2026), https://openamerica.io/bill/116-HR-478/.
Markdown link
[H.R. 478: Safe and Affordable Drugs from Canada Act of 2019](https://openamerica.io/bill/116-HR-478/)
Report a problem